Stockhub

SyneuRx International: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 September 2022

  • curprev 04:1804:18, 26 September 2022‎ 95.149.241.133 talk‎ 1,039 bytes +1,039‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == SyneuRx International (Taiwan) Corp., a clinical-stage biotech company, develops drugs for the treatment of unmet medical needs in central nervous system disorders in Taiwan. Its pipeline includes Pentarlandir, which is in Phase II clinical trials for COVID-19; Airnecflu that is in Phase I clinical trials for COVID-19; NaBen, which is in Phase III clinical trials for adult schizophrenia, as well as in Phase II clinical tria..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/SyneuRx_International’